© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, GSK plc (GSK) shows an Average True Range (ATR) of 1.26 and an Enterprise Value of 81.59B. Its average trading volume over the past 3 months is 4.56M, indicating liquidity. These fundamental metrics provide insight into GSK's underlying financial health and market activity.
| ATR | 1.26 |
| Enterprise Value | 81.59B |
| Avg Vol (3 Months) | 4.56M |
| Avg Vol (10 Days) | 7.99M |
GSK plc (GSK) technical indicators as of February 7, 2026: the SMA 20 is 17.15%, SMA 50 at 20.87%, and SMA 200 at 40.16%. The RSI 14 value is 83.89, suggesting its current momentum. These technical analysis signals help assess GSK's price trends and potential future movements.
| SMA 20 | 17.15% |
| SMA 50 | 20.87% |
| SMA 200 | 40.16% |
| RSI 14 | 83.89 |
GSK plc (GSK) stock performance overview as of February 7, 2026: The 52-week high is $60.37 (currently 1.03% below), and the 52-week low is $32.38 (currently 86.01% above). Over the past year, GSK's performance is 42.49%, compared to the S&P 500's 8.57% change.
| 52-Week High | 60.37 |
| 52-Week High Chg | +1.03% |
| 52-Week Low | 32.38 |
| 52-Week Low Chg | +86.01% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, GSK plc (GSK) stock's recent performance metrics show that over the last month, GSK is -2.18%, with a Year-to-Date (YTD) performance of -2.83%. Over the past year, the stock has seen a 42.49% change. These figures summarize GSK's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 60.37 | 60.37 | 60.37 | 60.37 | 60.37 | 60.37 |
| Low | 52.13 | 47.62 | 45.81 | 37.07 | 32.38 | 47.62 |
| Performance | -5.44% | -2.18% | +8.52% | +31.63% | +42.49% | -2.83% |
According to current financial data, GSK stock's P/E (TTM) ratio is 15.91, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for GSK, including P/S (2.79), P/B (5.44), and P/FCF (14.32), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GSK | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 15.91 | -1.23 | 69.86 | 32.59 |
| P/S (TTM) | 2.79 | 3.71 | 4.68 | 5.98 |
| P/B (TTM) | 5.44 | 0.22 | -0.4 | 5.47 |
| P/FCF (TTM) | 14.32 | -7.35 | 18.4 | 32.07 |